CD4+ T cells persist with their Eomes
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (1R01CA300217)
This publication has 10 references indexed in Scilit:
- Stem-like precursors of exhausted Th cells upheld by a Tox-Myb-Eomes transcriptional hierarchy propagate Th cell responses in chronic infectionImmunity, 2026
- The transcription factor Eomes drives a stemness program in CD4+ T cells that promotes anti-tumor immunity in response to immunotherapyImmunity, 2026
- Stem-like cells at the center of CD4 T cell differentiationTrends in Cell Biology, 2025
- Differentiation fate of a stem-like CD4 T cell controls immunity to cancerNature, 2024
- Eomes-dependent mitochondrial regulation promotes survival of pathogenic CD4+ T cells during inflammationJournal of Experimental Medicine, 2024
- Advancing beyond the twists and turns of T cell exhaustion in cancerScience Translational Medicine, 2022
- BCL6-dependent TCF-1+ progenitor cells maintain effector and helper CD4+ T cell responses to persistent antigenImmunity, 2022
- Tfh-cell-derived interleukin 21 sustains effector CD8+ T cell responses during chronic viral infectionImmunity, 2022
- Role of nuclear localization in the regulation and function of T-bet and Eomes in exhausted CD8 T cellsCell Reports, 2021
- High Levels of Eomes Promote Exhaustion of Anti-tumor CD8+ T CellsFrontiers in Immunology, 2018